Ophthalmology Billing

Maximize your reimbursements with ophthalmology-specialized billing. We help you manage the 2026 MPFS cuts, ambulatory surgery center (ASC) pre-authorization, new CPT codes, and facility payment changes for your practice.

Ophthalmology billing is experiencing one of its most turbulent years in recent history. The 2026 Medicare physician fee schedule included an 11% reduction in surgeon payment for cataract surgery (CPT 66984), the largest annual cut in three decades. Simultaneously, CMS finalized a 2.5% efficiency adjustment, reducing work relative value units (RVs) for non-time-based codes, restructured practice overhead payments to create a 30% payment gap between office-based and medical center-based procedures, and launched a new pre-authorization pilot program for ambulatory surgical centers (ASCs) for blepharoplasty and botulinum toxin procedures in 10 states.

At MedMaxbill, Inc., we offer comprehensive ophthalmology billing services designed to manage these complexities on your behalf. Our team of certified billing specialists understands the specific revenue cycle requirements of ophthalmology practices, from 2026 MPFS payment changes and new CPT codes to ambulatory surgery center pre-clearance compliance and cross-site and practice revenue optimization, ensuring your practice captures every dollar you earn while maintaining full regulatory compliance.
 

The 2026 Ophthalmology Billing Landscape: What's New
 

1. Medicare Conversion Factor Increase (with reservations)

CMS finalized two conversion factors for 2026: $33.4009** for nonqualified APM participants (a 3.26% increase) and $33.5675** for qualified providers (a 3.77% increase). Congress provided 2.5% of this increase through the "One Big Beautiful Bill," but this increase is temporary and expires on December 31, 2026.

2. 11% Reduction in Cataract Surgery Payment

The 2026 MPFS resulted in an 11% reduction in the surgeon payment for cataract surgery (CPT 66984), the largest annual reduction in three decades. For clinics with a high volume of cataract surgeries, this reduction represents a significant impact on revenue, requiring aggressive denial management and revenue cycle optimization to offset it.

3. Widening Payment Gap Between Practices and Medical Centers

CMS reduced the allocation of practice overhead for services provided at medical centers (ambulatory surgical centers and hospitals). The result is a wider payment gap between practices and medical centers.

4. New 2026 CPT Codes for Ophthalmology

The 2026 CPT update introduced several changes specific to ophthalmology:

Revised CPT Code:

92284 – Diagnostic dark adaptation examination (e.g., rod and cone sensitivity, rod-cone breakpoint), with interpretation and reporting (revised from screening to diagnostic)

New Category I Code:

92288 – Screening dark adaptation measurement (e.g., rod recovery intercept time), with interpretation and reporting

New Category III Codes (Emerging Technologies):

0996T – Scleral insertion and fixation of a capsular bag prosthesis containing an intraocular lens prosthesis, with vitrectomy, including removal of the lens or a dislocated IOL prosthesis, when performed

1010T – Analysis Computerized ophthalmic analysis of monocular eye movements using retina-based eye tracking without spatial calibration, including fixation, microsaccades, deviation, and horizontal saccades, unilateral or bilateral, with interpretation and reporting.

1012T – Motorized ab interno trepanation of the sclera (sclerostomy) or trabecular meshwork (trabeculostomy), one or more, including injection of antifibrotic agents, when performed.

Insurers may choose to reimburse Category III codes, so supporting documentation remains essential.

5. Preclearance Pilot for Ambulatory Surgical Centers (ASCs)

CMS launched a 5-year preclearance pilot program for selected ambulatory surgical center (ASC) services, including blepharoplasty and botulinum toxin injection procedures. The program is being implemented in 10 states in two phases:

Claims without prior approved authorization will be subject to payment review, which may result in delays or denials. The ambulatory surgical center (ASC) must submit the authorization, unlike hospital ambulatory care provider (HOPD) regulations, where physicians may submit it.

6. Increased Payments to ASCs

For ASCs that meet quality reporting requirements, CMS approved a 2.6% increase in payments, setting the conversion factor for 2026 at $56,322. Rates for cataract surgery were adjusted to $1,255.73, representing a 3.4% increase over 2025. Blepharoplasty procedures will receive a 15% increase in payments to ambulatory surgical centers.

7. Designation of MIGS as Device-Intensive Procedures

CMS designated MIGS codes 66989, 66991, and 0671T as device-intensive procedures and assigned them to APC code 5493, improving reimbursement alignment with costly glaucoma implants.

8. Updates on Medicare Advantage and Part D

CMS approved an average 5.06% increase in payments to Medicare Advantage plans, with a Part D out-of-pocket (OOP) cap of $2,100 by 2026. Medicare Advantage enrollment reached 54% of eligible beneficiaries by 2025, making contracting with commercial insurers increasingly important.
 

The Most Costly Ophthalmology Billing Errors
 

1. Service Site Coding Errors (Medical Center vs. Office)

With the payment gap projected to widen to 30% for SLT, 18% for YAG capsulotomy, and 26% for PRP by 2026, incorrect service site coding results in significant revenue losses. Generic billing systems using outdated service site logic lead to automatic underpayments.

2. Cataract Surgery Documentation Deficiencies

Cataract surgery is a high-volume service with frequent audits. CMS denials are often due to:

Deficient or incomplete documentation of functional disability

Insufficient justification of medical necessity

Excessive or unjustified preoperative testing

3. Failures in ASC pre-authorization

With the new ASC pre-authorization pilot program, the lack of authorization in pilot states triggers a pre-payment review for blepharoplasty and botulinum toxin claims, delaying payment for months.

4. Confusion between Evaluation and Management (E/M) codes and Ophthalmology consultation codes

Ophthalmology practices can bill E/M codes (99202–99215) or Ophthalmology consultation codes (92002–92014) depending on medical necessity. Practices that automatically use code 920xx without documenting the elements that justify interim or comprehensive examinations face denials.

5. E/M Coding for Same-Day Intravitreal Injection

An evaluation and management (E/M) may be billed together with an intravitreal injection (67028) only when the visit includes a separately identifiable and significant medical decision, beyond the routine work required for the injection. Failure to include modifier 25 or documentation of the separately identifiable service will result in denial.

6. Overuse of Modifier 25

Modifier 25 (Independent Evaluation and Management Service) is one of the most frequently audited modifiers in ophthalmology. Improper use of this modifier is a leading cause of claim denials in ophthalmology.

7. Billing for Refraction for Medicare Patients

Medicare legally excludes refraction (92015) from coverage. Facilities that do not obtain an ABN (Notice of Non-Coverage) and apply modifier GY face refunds.

8. Errors in Glaucoma Screening Frequency

G0117/G0118 glaucoma screening is limited to once a year (every 12 months) and requires meeting high-risk criteria: diabetes, family history, being African American over 50, or Hispanic over 65. Claims exceeding these frequency limits are automatically denied.

9. OCT/SCODI Coverage Requirements

CMS applies all SCODI coverage, documentation, and frequency requirements as per LCD L35038. Failure to document medical necessity or exceeding frequency limits will result in denials.

10. Expiration of Reimbursement Authorizations

Several ophthalmic medications lost their reimbursement authorization at the end of 2025 or will expire in 2026: Byooviz (Q5124), Iheezo (J2403), Cimerli (Q5128), Syfovre (J2781), Eylea HD (J0177), and Izervay (J2782). Facilities using outdated codes or billing for expired reimbursement authorization medications will face denials.
 

Our Comprehensive Ophthalmology Billing Services
 

MPFS 2026 Payment Optimization

We model the impact of the 11% cut in cataracts, the pay differential between centers and practices, and the 2.5% efficiency adjustment on your specific case mix. Our revenue cycle adjustments help you recover lost revenue through accurate coding, effective denial management, and site-of-service optimization.

Site-of-Service Coding (Center vs. Practice)

We verify correct point-of-sale coding for each claim and analyze the impact on site-of-service margin, particularly for SLT (30% difference), YAG capsulotomy (18% difference), and PRP (26% difference), to help you make data-driven decisions about where to perform procedures.

Compliance with Cataract Surgery Documentation

Our certified coders ensure that every cataract claim includes documentation of functional disability, a clear medical need, and appropriate preoperative testing, thus avoiding the three main causes of denial for CPT codes 66982/66984.

ASC Pre-Authorization Management

We manage the new 2026 pre-authorization workflows for blepharoplasty and botulinum toxin procedures in the 10 pilot states. Our team tracks authorization status in real time, links scheduling to authorization availability, and avoids pre-payment reviews.

Support for the 2026 CPT Code Transition

We ensure that all claims use the updated 2026 codes, including the revised 92284, the new 92288, and Category III codes 0996T, 1010T, and 1012T. Our team monitors the removed codes and updates billing workflows to prevent denials due to outdated coding.

Optimization of E/M vs. Ophthalmology Visit Codes

Our coders review documentation to select the correct code family: E/M (99202–99215) or ophthalmology visit (92002–92014), based on medical decision-making, time constraints, or the elements of the comprehensive examination.

Same-day intravitreal injection coding

We ensure that modifier 25 is applied only when documentation supports separately identifiable and significant evaluation and management (E/M) services beyond the injection itself. Our team prevents same-day E/M denials that impact ophthalmology appointments.

Glaucoma screening frequency tracking

We monitor the frequency limits of G0117/G0118 (once a year) and verify high-risk criteria (diabetes, family history, ethnicity, age) for each screening request.

Medication reimbursement and transfer management

We track the expiration dates of all ophthalmic medication transfers and ensure accurate billing for purchased and invoiced medications.

Denial and Appeal Management

Each denied request is reviewed and appealed with supporting documentation, including cataract functional impairment records, medical necessity justification via OCT/SCODI, and outpatient surgical center (ASC) prior authorization records. We implement preventative strategies based on denial trend analysis.

Reporting and Analytics

We offer real-time Revenue Cycle Management (RCM) dashboards that include denial rates, accounts receivable aging, margin analysis by service delivery location, and payer-specific trends.
 

Why MedMaxbill for Ophthalmology Billing?
 

Specialized Ophthalmology Expertise: 

Our coders work exclusively with ophthalmology cases, understanding Medicare’s unique standards for vision services, the selection of Evaluation and Management (E/M) codes versus ophthalmology consultations, and specific reimbursement for Ambulatory Surgical Centers (ASCs).

2026 Regulatory Compliance Ready: 

We are staying current with the 11% reduction in cataract payouts, the 2.5% efficiency adjustment, the pay differential between centers and practices, the ASC pre-authorization pilot program, new CPT codes, and prescription drug reimbursement expirations.

Proactive Denial Prevention: 

By identifying coding errors at the point of service, gaps in ASC pre-authorization, and deficiencies in cataract documentation before claims are submitted, we significantly reduce denial rates.

Cataract Revenue Protection: 

Our documentation and denial management support helps offset the 11% reduction in surgical payments and protect high-volume cataract revenue.

ASC Pre-Authorization Compliance: 

We manage the new pre-authorization workflows in pilot states, preventing pre-payment reviews and payment delays.

Dedicated Support: 

You'll have access to a dedicated account manager who understands your practice and is available to answer questions and provide updates.
 

Partner with MedMaxbill for Ophthalmology Billing Success
 

Billing in ophthalmology demands a specialized approach. With cataract surgeries declining by 11%, the widening gap in payments between centers and practices, new pre-authorization requirements for outpatient surgery centers, and increasing scrutiny of documentation, generalist billing companies often lose significant revenue and expose clinics to the risk of regulatory noncompliance.

At MedMaxbill, we combine industry expertise, advanced technology, and continuous monitoring to ensure your ophthalmology practice maximizes revenue and remains compliant with all regulations in 2026 and beyond.

Partner with MedMaxbill, Inc. and enjoy the peace of mind that comes with expert ophthalmic billing services. Let us handle the complexities of billing so you can focus on what matters most: providing exceptional eye care.